Home > Resources > Videos > ITV's Good Morning Britain - The Impact of Brexit on The Pharmaceutical Industry

ITV's Good Morning Britain - The Impact of Brexit on The Pharmaceutical Industry

Following a live debate with UK Independence Party Leader and anti-EU activist Nigel Farage, Aaron D Barzey of ADB Medical, was invited onto ITV's Good Morning Britain show to discuss the potential impact of the UK leaving the European Union to the pharmaceutical industry.

Spotlight

Grupo Medinfar

MEDINFAR is a fully integrated Portuguese Pharmaceutical Company headquartered in Lisbon. Founded in 1970, MEDINFAR is focused in R&D, Production, Distribution, Marketing & Sales. Besides its own brands it markets licensed products in partnerships with several top international pharmaceutical companies. MEDINFAR is the Nº1 Portuguese Company in Dermatology as in Consumer Health. MEDINFAR has a wide range of products from Prescription Medicines to Generics, OTC/Consumer Health products and veterinary products. In 2001, with the acquisition of the manufacturing unit, FARMALABOR, Medinfar increased its productive capacity. This unit has an area of 47.000 m2 and produced in 2013 around 15 million packages.

OTHER VIDEOS

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now
MORE VIDEOS

Spotlight

Grupo Medinfar

MEDINFAR is a fully integrated Portuguese Pharmaceutical Company headquartered in Lisbon. Founded in 1970, MEDINFAR is focused in R&D, Production, Distribution, Marketing & Sales. Besides its own brands it markets licensed products in partnerships with several top international pharmaceutical companies. MEDINFAR is the Nº1 Portuguese Company in Dermatology as in Consumer Health. MEDINFAR has a wide range of products from Prescription Medicines to Generics, OTC/Consumer Health products and veterinary products. In 2001, with the acquisition of the manufacturing unit, FARMALABOR, Medinfar increased its productive capacity. This unit has an area of 47.000 m2 and produced in 2013 around 15 million packages.

Events